Ottawa – Every day in Canada, someone’s life is forever changed by a breast cancer diagnosis. Whether it’s a young mother chasing her dreams or someone enjoying the next chapter of retirement, breast cancer touches all ages and backgrounds. However, access to care, particularly early detection, varies drastically depending on where you live. This Breast Cancer Awareness Month, we explore …
Ottawa – The ParaTough Cup 2024/25 season began with a bang last Friday, raising $72,000 for the IGNITE campaign that supports the Para sport development in Canada. At the latest stop of the Paralympic Foundation of Canada’s groundbreaking fundraising initiative, the ParaTough Cup welcomed 12 teams at the Richmond Olympic Oval in Vancouver, vying for the title of ParaTough Cup champions. Teams consisted of Canadian …
Hamilton – Pfizer Canada and McMaster University are proud to announce a significant project aimed at addressing critical gaps in health equity in the development and delivery of vaccines. Pfizer Canada’s investment of $500,000 to McMaster’s Global Nexus is aimed at supporting McMaster University’s commitment to inclusive excellence in research by training emerging scholars from equity-deserving groups in the field …
KIRKLAND –NURTEC ODT® (rimegepant) is now available in Canada for use in the acute treatment of migraine, with or without aura in adults older than 18 years of age.[iii] NURTEC is an orally disintegrating calcitonin gene-related peptide (CGRP) receptor antagonist tablet. It was approved by Health Canada on December 1, 2023. Classified as one of the 10 most disabling medical illnesses …
KIRKLAND – Pfizer Canada was named one of Montreal’s Top Employers for 2024 by Mediacorp Canada Inc. Pfizer has had a long-standing presence in the Greater Montreal area, providing a positive work environment and benefits offerings to its Montreal-based employees for over 70 years. “At our core, we are about helping people live healthier lives. As Pfizer celebrates 175 years of working …
KIRKLAND – Pfizer Canada ULC announced that Health Canada approved BEQVEZ (fidanacogene elaparvovec), an adeno-associated viral (AAV) vector-based gene therapy for the treatment of adults (aged 18 years or older) with moderately severe to severe hemophilia B (congenital Factor IX (FIX) deficiency) who are negative for neutralizing antibodies to variant AAV serotype Rh74. “Pfizer has more than 30 years of …
The two winners of the Canadian Skin of Colour & Diversity Scholarship will receive funds to implement their ideas on addressing care gaps among underrepresented Canadians. KIRKLAND – Pfizer Canada and the Skin Spectrum Summit are pleased to announce the winners of the new Canadian Skin of Colour & Diversity Scholarship program, which aims to improve dermatological care for underrepresented populations, …
KIRKLAND – The National Advisory Committee on Immunization (NACI) recently provided a strong recommendation for PREVNAR 20 for the following adult populations who have not been previously immunized with a pneumococcal vaccine or whose vaccination status is unknown: Adults ≥65 years of age Adults 50-64 years of age living with risk factors placing them at higher risk of pneumococcal disease. …
KIRKLAND – Rethink Breast Cancer (Rethink) and Pfizer Canada are proud to announce three recipients who will collectively receive over $200,000 in grants for their work in developing innovative strategies to measurably improve the quality of care for people living with metastatic breast cancer (mBC). Guided by the unique and unmet needs identified by people living with mBC and their families, …
The Canadian Skin of Colour & Diversity Scholarship program will provide funds for dermatology residents to implement their ideas on addressing care gaps among underrepresented Canadians. KIRKLAND– Together with the Skin Spectrum Summit, Pfizer Canada has announced the new Canadian Skin of Colour & Diversity Scholarship program to improve dermatological care for underrepresented populations, including those with deeper skin tones, …
